DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017
A review of the Drug Master Files (DMFs) submitted to the United
States Food and Drug Administration